Scientists have developed a protein-based COVID-19 vaccine candidate that mimics the shape of the virus to trigger robust antibody response in animals. In the study published in the journal ACS Central Science, the researchers immunised mice with nanoparticles that mimic SARS-CoV-2, the virus that causes COVID-19, by displaying multiple copies ...
Moderna has published data from adults aged 56 years and older who received its COVID-19 vaccine. Results from the small cohort suggest the vaccine triggers comparable immune responses in younger ...